Increased iNOS-expressing macrophage in long-term surviving rat small-bowel grafts

American Journal of Surgery

Volumn 194, Issue 2, 2007, Pages 248-254

  Li, Xiaosong ^a,b   Chen, Yan ^b   Tian, Lina ^b,c   Lui, Vincent C H ^b   Tam, Paul K H ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Chronic rejection; Fibrosis; FK506; rapamycin; Vasculopathy

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; RAPAMYCIN; TACROLIMUS;

ACUTE GRAFT REJECTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL OCCLUSION; CELL INFILTRATION; CHRONIC GRAFT REJECTION; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; EXPERIMENTAL MODEL; EXPERIMENTAL RAT; GRAFT RECIPIENT; GRAFT SURVIVAL; HISTOPATHOLOGY; INTESTINAL FIBROSIS; INTESTINE GRAFT; LONG TERM CARE; MACROPHAGE FUNCTION; MALE; MESENTERIC BLOOD VESSEL OCCLUSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; VASCULAR FIBROSIS;

ANIMALS; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE AGENTS; INTESTINE, SMALL; MACROPHAGES; MALE; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, INBRED STRAINS; SIROLIMUS; TACROLIMUS;

EID: 34347231911     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2006.09.032     Document Type: Article

References (27)

1. Guo W.H., Tian L., Dallmann M.J., et al. Comparative study of allograft survival of heterotopic and orthotopic small bowel transplantation in rat. Transplantation 75 (2003) 1895-1897
2. Cecka J.M. Outcome statistics of renal transplants with an emphasis on long-term survival. Clin Transplant 8 (1994) 324-327
3. Keck B.M., Bennett L.E., Rosendale J., et al. Worldwide thoracic organ transplantation: a report from the UNOS/ISHLT International Registry for Thoracic Organ Transplantation. Clin Transpl (1999) 35-49
4. Smith C.M., Davies D.B., and McBride M.A. Liver transplantation in the United States: a report from the UNOS Liver Transplant Registry. Clin Transpl (1999) 23-34
5. Grant D. Intestinal transplantation: 1997 report of the international registry. Intestinal Transplant Registry. Transplantation 67 (1999) 1061-1064
6. Kumar N., and Grant D. Gastrointestinal transplantation: an update. Liver Transpl 6 (2000) 515-519
7. Shirwan H. Chronic allograft rejection. Do the Th2 cells preferentially induced by indirect alloantigen recognition play a dominant role?. Transplantation 68 (1999) 715-726
8. Wiederrecht G.J., Sabers C.J., Brunn G.J., et al. Mechanism of action of rapamycin: new insights into the regulation of G1-phase progression in eukaryotic cells. Prog Cell Cycle Res 1 (1995) 53-71
9. Li Y., Li X.C., Zheng X.X., et al. Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance. Nat Med 5 (1999) 1298-1302
10. Hidalgo M., and Rowinsky E.K. The rapamycin-sensitive signal transduction pathway as a target for cancer therapy. Oncogene 19 (2000) 6680-6686
11. Kurose I., Wolf R., Grisham M.B., et al. Modulation of ischemia/reperfusion-induced microvascular dysfunction by nitric oxide. Circ Res 74 (1994) 376-382
12. Poston R.S., Billingham M., Hoyt E.G., et al. Rapamycin reverses chronic graft vascular disease in a novel cardiac allograft model. Circulation 100 (1999) 67-74
13. Ikonen T.S., Gummert J.F., Hayase M., et al. Sirolimus (rapamycin) halts and reverses progression of allograft vascular disease in nonhuman primates. Transplantation 70 (2000) 969-975
14. Kimura H., Katsuramaki T., Isobe M., et al. Role of inducible nitric oxide synthase in pig liver transplantation. J Surg Res 111 (2003) 28-37
15. Strestikova P., Plskova J., Filipec M., et al. FK 506 and aminoguanidine suppress iNOS induction in orthotopic corneal allografts and prolong graft survival in mice. Nitric Oxide 9 (2003) 111-117
16. Albrecht E.W., van Goor H., Tiebosch A.T., et al. Nitric oxide production and nitric oxide synthase expression in acute human renal allograft rejection. Transplantation 70 (2000) 1610-1616
17. Szabolcs M., Michler R.E., Yang X., et al. Apoptosis of cardiac myocytes during cardiac allograft rejection. Relation to induction of nitric oxide synthase. Circulation 94 (1996) 1665-1673
18. Koglin J., Granville D.J., Glysing-Jensen T., et al. Attenuated acute cardiac rejection in NOS2 -/- recipients correlates with decreased apoptosis. Circulation 99 (1999) 836-842
19. Weis M., and von Scheidt W. Cardiac allograft vasculopathy: a review. Circulation 96 (1997) 2069-2077
20. Koglin J. Pathogenetic mechanisms of cardiac allograft vasculopathy-impact of nitric oxide. Z Kardiol 89 suppl 9 (2000) 24-27
21. Damoiseaux J.G., Dopp E.A., Calame W., et al. Rat macrophage lysosomal membrane antigen recognized by monoclonal antibody ED1. Immunology 83 (1994) 140-147
22. Cao W., Mohacsi P., Shorthouse R., et al. Effects of rapamycin on growth factor-stimulated vascular smooth muscle cell DNA synthesis. Inhibition of basic fibroblast growth factor and platelet-derived growth factor action and antagonism of rapamycin by FK506. Transplantation 59 (1995) 390-395
23. Marx S.O., Jayaraman T., Go L.O., et al. Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells. Circ Res 76 (1995) 412-417
24. Duffield J.S., Forbes S.J., Constandinou C.M., et al. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Invest 115 (2005) 56-65
25. Hagemann T., Robinson S.C., Schulz M., et al. Enhanced invasiveness of breast cancer cell lines on cocultivation with macrophages is caused by TNF-alpha dependent upregulation of matrix metalloproteases. Carcinogenesis 25 (2004) 1543-1549
26. Marx J. Cancer research. Inflammation and cancer: the link grows stronger. Science 306 (2004) 966-968
27. Sarkar R., Meinberg E.G., Stanley J.C., et al. Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells. Circ Res 78 (1996) 225-3